1,207 results on '"Lennon, Vanda A."'
Search Results
202. Case Control Analysis of Glycine Receptor Autoimmunity (P5.125)
203. Specificity of glial fibrillary acidic protein IgG autoantibody (GFAP-IgG) for Autoimmune Meningoencephalomyelitis Diagnosis (S20.002)
204. Placental transmission of AQP4-IgG to neonate from mothers with neuromyelitis optica spectrum disorder (NMOSD) (S20.006)
205. Clinical-pathologic correlations in voltage-gated Kv1 potassium channel complex-subtyped autoimmune painful polyneuropathy
206. Effects of neuromyelitis optica–IgG at the blood–brain barrier in vitro
207. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy
208. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum
209. NMDAR encephalitis: which specimens, and the value of values
210. A comparison of tissue-based and recombinant protein–based assays for detecting PCA-Tr/DNER-IgG: Table
211. Memory in autoimmune NMDA receptor encephalitis: an issue for B cells and patients
212. Frequency of Synaptic Autoantibody Accompaniments and Neurological Manifestations of Thymoma
213. Clinical utility of testing AQP4-IgG in CSF
214. Epidemiology of Aquaporin-4 Autoimmunity and Neuromyelitis Optica Spectrum: A Comparison of Two Ethnically Divergent Populations (P3.003)
215. Rho GTPase Activating Protein 26 (ARHGAP26)-Igg Autoimmunity: Frequency and Clinical Associations (P3.346)
216. Clinical utility of testing cerebrospinal fluid (CSF) for AQP4-IgG: A guideline to improve physician ordering of AQP4-IgG diagnostic test. (S12.003)
217. Medusa Head-Type Neuronal Autoantibody Inositol Triphosphate Receptor-1 (ITPR1)-IgG: Frequency, Clinical Phenotype and Cancer Associations (P5.300)
218. Animal extremists' threats to neurologic research continue: Neuroreality IIAuthor Response
219. P/Q- and N-type calcium-channel antibodies: Oncological, neurological, and serological accompaniments
220. An Autoimmune Basis for Diabetes-Related Chorea?
221. Herpes simplex virus 1 encephalitis associated with voltage-gated calcium channel autoimmunity
222. Animal extremists' threats to neurologic research continue
223. Aquaporin-4 autoimmunity
224. Necrotizing Autoimmune Myopathy: Comparison of Clinical Features and Treatment Outcomes among Different Etiologies (S17.002)
225. Short Myelitis Lesions in Aquaporin-4-IgG-positive Neuromyelitis Optica Spectrum Disorders (S46.005)
226. Autoantibodies in the Postural Tachycardia Syndrome (P1.272)
227. Ma2 Autoantibody-Negative Multifocal Paraneoplastic Neurological Disorder Associated with Metastatic Testicular Cancer. (P4.049)
228. Autoimmune Cerebellar Ataxia: Treatment Responses and Outcomes in 118 Patients (I4-4B)
229. Prolonged QTc Interval in Patients Seropositive for Ganglionic (α-3) Acetylcholine Receptor Autoantibody (P1.274)
230. Effects of Neuromyelitis Optica(NMO)-IgG for leukocyte transmigration at the Blood-Brain Barrier (S46.003)
231. Prospective Evaluation of Maintenance Plasma Exchange (mPLEX) for Attack Prevention in Neuromyelitis Optica Spectrum Disorder: Preliminary Feasibility, Safety, and Efficacy Data (P5.265)
232. Autoimmune Cerebellar Ataxia: Treatment Responses and Outcomes in 118 Patients (P2.111)
233. Progressive Autoimmune Neuromyotonia with Low Voltage-Gated Potassium Channel-Complex IgG and CASPR2-IgG Following Remote Inflammatory Polyradiculoneuropathy (P4.019)
234. Short Myelitis Lesions in Aquaporin-4-IgG–Positive Neuromyelitis Optica Spectrum Disorders
235. Comment on “Thiamine Deficiency Promotes T Cell Infiltration in Experimental Autoimmune Encephalomyelitis: The Involvement of CCL2”
236. Seroprevalence of Aquaporin-4–IgG in a Northern California Population Representative Cohort of Multiple Sclerosis
237. NMO-IgG Status in Fulminant Inflammatory CNS Demyelinating Disorders
238. Anti-Neuronal Nuclear Antibody 3 Autoimmunity Targets Dachshund Homolog 1
239. Caveolae-Associated Protein (cavin)-4 Autoantibodies in Immune Mediated Rippling Muscle Disease
240. Testing for N-type Voltage Gated Calcium Channel Antibody has Limited Utility in Evaluating Patients With Suspected Lambert-Eaton Myasthenic Syndrome
241. GENETIC CONTROL OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS IN MICE
242. IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients.
243. Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica.
244. Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic Fc receptor.
245. Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica.
246. Microtubule-associated protein 1B: Novel paraneoplastic biomarker.
247. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients.
248. Effects of neuromyelitis optica--IgG at the blood--brain barrier in vitro.
249. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy.
250. Paraneoplastic Neurological Autoimmunity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.